Skip to main content

Breadcrumb

  1. Home

New

Rate of Timely Follow-up on Abnormal Screening Mammograms for Breast Cancer Detection

  • This electronic Clinical Quality Measure (eCQM) reports the percentage of female patients aged 40 to 75 years with at least one abnormal screening (BI-RADS 0) or screening-to-diagnostic (BI-RADS 4, 5) mammogram during the measurement period (i.e., calendar year) who received timely diagnostic resolution defined as either follow-up imaging with negative/benign/probably benign results or a breast biopsy within 60 days after their index (i.e., first) abnormal screening mammogram.

    CBE ID
    4700e

Rate of Timely Follow-up on Positive Stool-based Tests for Colorectal Cancer Detection

  • This electronic Clinical Quality Measure (eCQM) reports the percentage of patients aged 45 to 75 years with at least one positive stool-based colorectal cancer screening test (i.e., high-sensitivity guaiac fecal occult blood test, fecal immunochemical test, or Cologuard) during the measurement period (i.e., calendar year) who completed a colonoscopy within 180 days after their index (i.e., first) positive stool-based test result date.

    CBE ID
    4705e

Ratio of observed over predicted rates for diagnosis of cognitive impairment of any stage

  • The measure captures the ratio of the number of patients, who are attributed to a clinician or practice, with a diagnosis of any stage of cognitive impairment over the expected number of cases based on a predictive model. Once the clinician’s or practice’s O/E ratio (i.e., ratio of the observed and expected rates) is calculated, a computation of its associated standard error (SE) can be used to draw inference whether the O/E ratio is significantly different from 1 or not.
    CBE ID
    3729

Ratio of observed over predicted rates for diagnosis of dementia

  • Ratio of the number of patients 65 and older diagnosed with dementia attributed to a clinician or practice over the number of cases predicted based on the demographic profile of that clinician or practice. Once the clinician’s or practice’s O/E ratio (i.e., ratio of the observed and expected rates) is calculated, a computation of its associated standard error (SE) can be used to draw inference whether the O/E ratio is significantly different from 1 or not.
    CBE ID
    3672

Ratio of observed over predicted rates for diagnosis of mild cognitive impairment

  • Ratio of the number of patients 65 and older diagnosed with mild cognitive impairment attributed to a clinician or practice over the number predicted based on the demographic profile of that clinician or practice. Once the clinician’s or practice’s O/E ratio (i.e., ratio of the observed and expected rates) is calculated, a computation of its associated standard error (SE) can be used to draw inference whether the O/E ratio is significantly different from 1 or not.
    CBE ID
    3707

Risk Adjusted Post-Ambulance Provider Triage Emergency Department (ED) Visit Rate Measure

  • The Risk Adjusted Post-Ambulance Provider Triage Emergency Department (ED) Visit Rate Measure (shorthand: Post-Triage ED Visit Rate Measure) assesses the quality of the triage and decision making by ambulance providers who transport low acuity patients to an alternative destination (non-ED location), or facilitate Treatment In Place (TIP), by identifying whether patients have a subsequent ED visit or death within three days.

    CBE ID
    3751

Serious Illness Survey for Home-Based Programs

  • The proposed measures are derived from the Serious Illness Survey for Home-Based Programs, a 36-item questionnaire designed to measure the care experiences of patients receiving care from home-based serious illness programs. Home-based serious illness programs provide care for seriously ill patients at their private residences (i.e., in their homes or assisted living facilities, not in institutions like skilled nursing facilities).
    CBE ID
    3726

STI Testing for People with HIV

  • Percentage of patients 13 years of age and older with a diagnosis of HIV who had tests for syphilis, gonorrhea, and chlamydia performed within the measurement period.

    CBE ID
    3755e